These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 324476)

  • 1. Effect of probenecid on the concentration of the lumbar cerebrospinal fluid acidic metabolites of tyramine, octopamine, dopamine and norepinephrine.
    Karoum F; Bunney W; Gillin JC; Jimerson D; Van Kammen D; Wyatt RJ
    Biochem Pharmacol; 1977 Apr; 26(7):629-32. PubMed ID: 324476
    [No Abstract]   [Full Text] [Related]  

  • 2. The effect of probenecid on catecholamine metabolites in human cerebrospinal fluid analyzed by mass fragmentography.
    Gordon EK; Oliver J; Kopin IJ
    Life Sci; 1975 May; 16(10):1527-31. PubMed ID: 1195975
    [No Abstract]   [Full Text] [Related]  

  • 3. Dopamine, noradrenaline and serotonin spinal fluid metabolites in temporal lobe epileptic patients with schizophrenic symptomatology.
    Peters JG
    Eur Neurol; 1979; 18(1):15-8. PubMed ID: 436860
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of clorgyline and pargyline on deaminated metabolites of norepinephrine, dopamine and serotonin in human cerebrospinal fluid.
    Major LJ; Murphy DL; Lipper S; Gordon E
    J Neurochem; 1979 Jan; 32(1):229-31. PubMed ID: 759576
    [No Abstract]   [Full Text] [Related]  

  • 5. Clinical application of the probenecid test for measurement of monoamine turnover in the CNS.
    Faull KF; Kraemer HC; Barchas JD; Berger PA
    Biol Psychiatry; 1981 Sep; 16(9):879-99. PubMed ID: 6170352
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cerebrospinal fluid studies of monoamine metabolism in schizophrenia.
    van Kammen DP; Peters J; van Kammen WB
    Psychiatr Clin North Am; 1986 Mar; 9(1):81-97. PubMed ID: 2421272
    [TBL] [Abstract][Full Text] [Related]  

  • 7. On the elimination of 5-hydroxyindoleacetic acid and homovanillic acid from cerebrospinal fluid.
    Andersson H; von Essen C; Roos BE
    Acta Pharmacol Toxicol (Copenh); 1973; 32(1):129-38. PubMed ID: 4741033
    [No Abstract]   [Full Text] [Related]  

  • 8. Plasma concentrations of some acidic and alcoholic metabolites derived from m- and p-tyramine, octopamine and catecholamines in humans.
    Karoum F; Moyer-Schwing J; Potkin SG; Wyatt RJ
    Commun Psychopharmacol; 1977; 1(4):343-52. PubMed ID: 354855
    [No Abstract]   [Full Text] [Related]  

  • 9. [Study on dopamine metabolite in cerebrospinal fluid of schizophrenics and epilepsics].
    Jiang S; Chen X; Liao W
    Hunan Yi Ke Da Xue Xue Bao; 1998; 23(2):155-6. PubMed ID: 10681831
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cerebrospinal fluid probenecid studies: a reinterpretation.
    Cowdry RW; Ebert MH; van Kammen DP; Post RM; Goodwin FK
    Biol Psychiatry; 1983 Nov; 18(11):1287-99. PubMed ID: 6197100
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence for central hypertyraminemia in hepatic encephalopathy.
    Faraj BA; Camp VM; Ansley JD; Scott J; Ali FM; Malveaux EJ
    J Clin Invest; 1981 Feb; 67(2):395-402. PubMed ID: 7462424
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CSF monoamine metabolites in depression and schizophrenia.
    Berger PA; Faull KF; Kilkowski J; Anderson PJ; Kraemer H; Davis KL; Barchas JD
    Am J Psychiatry; 1980 Feb; 137(2):174-80. PubMed ID: 7352572
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determination of acidic metabolites of biogenic amines in human aqueous humour by gas chromatography--negative ion chemical ionisation mass spectrometry.
    Watson DG; McGhee CN; Midgley JM; Zhou P; Doig WM
    J Neurochem; 1992 Jan; 58(1):116-20. PubMed ID: 1727423
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monoamine metabolite concentrations in the cerebrospinal fluid of normal and narcoleptic dogs.
    Faull KF; Barchas JD; Foutz AS; Dement WC; Holman RB
    Brain Res; 1982 Jun; 242(1):137-43. PubMed ID: 6179569
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biochemical aids in the diagnosis of Parkinson's disease.
    Chase TN; Eng N; Gordon EK
    Ann Clin Lab Sci; 1976; 6(1):4-10. PubMed ID: 1247283
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Toward a biochemical classification of depression.
    van Praag HM
    Adv Biochem Psychopharmacol; 1974; 11(0):357-68. PubMed ID: 4845704
    [No Abstract]   [Full Text] [Related]  

  • 17. Noradrenergic overactivity in chronic schizophrenia: evidence based on cerebrospinal fluid noradrenaline and cyclic nucleotide concentrations.
    Gomes UC; Shanley BC; Potgieter L; Roux JT
    Br J Psychiatry; 1980 Oct; 137():346-51. PubMed ID: 6160894
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of pimozide on CSF norepinephrine in schizophrenia.
    Sternberg DE; van Kammen DP; Lake CR; Ballenger JC; Marder SR; Bunney WE
    Am J Psychiatry; 1981 Aug; 138(8):1045-50. PubMed ID: 7258379
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Changes in ventricular dopamine and homovanillic acid concentrations in hydrocephalic patients (author's transl)].
    Kawano T; Tsujimura M; Mori K; Eujita Y
    Neurol Med Chir (Tokyo); 1980 Apr; 20(4):373-8. PubMed ID: 6155625
    [No Abstract]   [Full Text] [Related]  

  • 20. Determination of isomeric acid dopamine metabolites in human cerebrospinal fluid by mass fragmentography.
    Bertilsson L; Palmér L
    Life Sci; 1973 Oct; 13(7):859-66. PubMed ID: 4766262
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.